Evidence map›Paper›PMID 41982696›Full record

ArticleTranslational lung cancer research2026

Prognostic implications of dominant lesion misidentification in multiple primary lung cancer.

Bowen Zhao, Xiaoyun Su, Yu Huang, Xiaoyu Han, Yan Li, Chi Zhang, Zuhan Gen, Qiuyu Len, Shiwen He, Shiwen Fan and 5 more

Abstract read
In one paragraph

Article in Translational lung cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Bowen Zhao *Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiaoyun Su *Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yu Huang *Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiaoyu HanDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yan LiDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chi ZhangDepartment of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zuhan GenDepartment of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Qiuyu LenDepartment of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shiwen HeDepartment of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shiwen FanDepartment of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ming ChenDepartment of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Kuo LiDepartment of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Fan Yang *Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Guangyao Wu *Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yongde Liao *Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Surgical resection remains the cornerstone of treatment for multiple primary lung cancer (MPLC). Given that the dominant lesion (DL) primarily determines the prognosis of patients with MPLC, accurate identification of the DL is crucial. This study aims to investigate the prognostic impact of preoperative misidentification of the DL on patients with MPLC. Methods: Patients with clinical stage I MPLC between January 2014 and December 2021 were retrospectively collected. The DL was preoperatively identified based on the mean diameter of lesions on computed tomography (CT) images, with postoperative confirmation via pathological examination results. Patients were categorized into the Inconsistent group (IG) if preoperative misidentification of the DL led to two scenarios: (I) a discrepancy between the actual surgical procedure performed and the optimal surgical approach retroactively determined based on postoperative assessment; or (II) prioritized resection of secondary lesions followed by staged resection of the DL. All remaining patients, in whom preoperative DL identification was consistent with postoperative confirmation and surgical procedures aligned with the DL-guided strategy, were assigned to the Consistent group (CG). Propensity score matching (PSM) was implemented to mitigate confounding effects from intergroup clinical characteristic variances. Overall survival (OS) and recurrence-free survival (RFS) were assessed, with prognostic factors evaluated using multivariate cox regression analysis. Results: From an initial cohort of 159 patients, 78 patients were selected through 1:2 PSM. All covariates demonstrated satisfactory balance between groups after matching, with no statistically significant differences observed. Five-year OS rates were 96.15% [95% confidence interval (CI): 91.7-98.3%] for IG and 98.08% (95% CI: 94.2-99.4%) for CG. Corresponding RFS rates were 62.86% (95% CI: 54.8-70.1%) and 91.54% (95% CI: 85.1-95.3%), respectively. Multivariable analysis identified inconsistent surgery [hazard ratio (HR) 5.341; 95% CI: 1.085-26.282; P=0.04] and receipt of postoperative adjuvant therapy (HR 5.613; 95% CI: 1.359-23.174; P=0.02) as independent risk factors of RFS. Conclusions: In patients with MPLC, preoperative misidentification of the DL may potentially affect prognosis due to the difference of surgical approach. Consequently, accurate preoperative identification of DLs is essential for optimizing surgical planning.

Indexed as

Dominant lesion (DL)multiple primary lung cancer (MPLC)overall survival (OS)recurrence-free survival (RFS)

Identifiers

PMID41982696
PMCPMC13071683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.